Literature DB >> 10463871

Quantitative autoradiographic visualization and pharmacology of FP-prostaglandin receptors in human eyes using the novel phosphor-imaging technology.

T L Davis1, N A Sharif.   

Abstract

Quantitative autoradiographic visualization of FP prostaglandin receptors was determined in postmortem human eye sections using [3H]PGF2alpha and the novel phosphor-imaging technology coupled with computerized image analysis. Densitometric analysis of digital images obtained after a 19-day screen-exposure revealed FP receptors to be highly concentrated in the longitudinal ciliary muscle (12,741 digital light units [DLU/mm2]), iris sphincter muscle (19,261 DLU/mm2) and retina (9,544 DLU/mm2), with lesser amounts (1,558-3,776 DLU/mm2) in five other ocular structures (n = 3-4 donors). The highest percentage specific binding was in the iris sphincter and longitudinal ciliary muscle (78-73%) and lowest in the lens (12%). Binding of [3H]PGF2alpha to the longitudinal ciliary and iris sphincter muscles and retina was concentration-dependently and potently displaced by known FP-receptor-selective compounds such as cloprostenol (Ki = 13-37 nM), fluprostenol (Ki = 56-98 nM), PHXA85 (Ki = 181-206 nM) and latanoprost (isopropyl ester of PHXA85; Ki = 0.43-4.5 microM) (from up to 4 donor eyes). These quantitative phosphor-imaging autoradiography data provide further evidence for the presence of FP receptors in human longitudinal ciliary muscle, one of the tissues involved in the intraocular pressure lowering effects of FP-class prostaglandins. The quantitative localization of FP receptors in the human iris, iris sphincter muscle, and retina represent interesting new observations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463871     DOI: 10.1089/jop.1999.15.323

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  10 in total

Review 1.  Effects of travoprost in the treatment of open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis.

Authors:  Jin-Wei Cheng; Gui-Lin Xi; Rui-Li Wei; Ji-Ping Cai; You Li
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

Review 2.  Effects of prostaglandin analogues on aqueous humor outflow pathways.

Authors:  Nelson S Winkler; Michael P Fautsch
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-20       Impact factor: 2.671

3.  Discovery to Launch of Anti-allergy (Emadine; Patanol/Pataday/Pazeo) and Anti-glaucoma (Travatan; Simbrinza) Ocular Drugs, and Generation of Novel Pharmacological Tools Such as AL-8810.

Authors:  Najam A Sharif
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-05

4.  Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.

Authors:  T L Davis; N A Sharif
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

5.  Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand.

Authors:  N A Sharif; G W Williams; T L Davis
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Association between glaucoma eye drops and hyperemia.

Authors:  Masahide Yanagi; Yoshiaki Kiuchi; Yuki Yuasa; Tsuyoshi Yoneda; Tamaki Sumi; Yasuhiro Hoshikawa; Masahiko Kobayashi; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2016-02-04       Impact factor: 2.447

7.  Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo.

Authors:  Akiyasu Kanamori; Maiko Naka; Masahide Fukuda; Makoto Nakamura; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-24       Impact factor: 3.117

8.  Principles of Ocular Pharmacology.

Authors:  Yong Park; Dorette Ellis; Brett Mueller; Dorota Stankowska; Thomas Yorio
Journal:  Handb Exp Pharmacol       Date:  2017

9.  Crystallins are regulated biomarkers for monitoring topical therapy of glaucomatous optic neuropathy.

Authors:  Verena Prokosch; Maurice Schallenberg; Solon Thanos
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

10.  Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model.

Authors:  Maurice Schallenberg; Verena Prokosch; Solon Thanos
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.